Skip to main content
. 2022 Jan 7;14(2):295. doi: 10.3390/cancers14020295

Figure 1.

Figure 1

Representative samples of E-cadherin staining. Micrographs of representative hematoxylin and eosin (H&E) stained sections and E-cadherin immunohistochemistry (IHC) of three selected E-cadherin heterogeneous breast cancers included in this study (scale bar IHC, 200 μm). (i) ML3 CDH1MT, (ii) ML6 CDH1WT and (iii) ML10 CDH1WT. Note in ML10, the aberrant component is DCIS.